客户端从BiP加载到Grp94的机制及其被选择性抑制剂破坏
Tara P Azam1, Luna Han1, Erin E Deans1
1Department of Biochemistry at Brandeis University, Waltham, MA, 02453, USA.
Nature communications
|April 15, 2025
概括
热冲击蛋白90 (Hsp90) 抑制剂会影响客户端蛋白质的负载. 一些Hsp90抑制剂破坏了加载过程,为癌症药物设计提供了新的策略.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 结构生物学 结构生物学
背景情况:
- 热冲击蛋白90 (Hsp90) 是一个关键的分子伴侣和一个验证的癌症药物标.
- 许多ATP竞争性Hsp90抑制剂正在进行癌症治疗的临床试验.
- 通过Hsp90抑制剂影响客户端蛋白转移和加载的精确机制仍然不完全理解.
研究的目的:
- 为了研究Hsp90抑制剂如何影响客户端蛋白质的输送,加载和捕获步骤.
- 阐明 Hsp70 陪伴器 BiP 在促进客户端加载到 Hsp90 平行模拟器 Grp94.4 上的作用.
- 确定控制抑制剂对Hsp90客户端负载的影响的结构性决定因素.
主要方法:
- 在不同Hsp90抑制剂的存在下对ER居住的BiP/Grp94护卫系统 (Hsp70/Hsp90对应物) 的比较分析.
- 生物化学试验检查Grp94.4中的BiP介导的构造变化.
- 结构研究以了解抑制剂相互作用及其对三元复合体形成的影响.
主要成果:
- 特定的Hsp90抑制剂差异调节BiP诱导Grp94.4的客户端负载构造的能力.
- 某些抑制剂阻断BiP驱动的结构变化,导致BiP/客户端/Grp94三元复合物的不稳定.
- 通过Hsp90抑制剂的一个子集确定了选择性抑制客户端负载的结构基础.
结论:
- BiP 通过 ER 和细胞质 Hsp70/Hsp90 系统之间保留的机制,积极驱动 Grp94 进入客户端负载能力状态.
- 了解这些客户端加载动态揭示了特定抑制剂如何破坏Hsp90功能.
- 这些发现为开发新的,合理设计的针对Hsp90的癌症疗法提供了基础.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.2K
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
3.1K
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Long-patch Base Excision Repair
6.9K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
6.9K
GPCR Desensitization
5.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K
